Atea Pharmaceuticals, Inc.

Atea Pharmaceuticals, Inc. financial statements

Atea Pharmaceuticals, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

RevenueUSD 0EODHD
Net income−USD 158.35M10-K
Cash and equivalentsUSD 95.71M10-Q
Total debtUSD 843KEODHD

Atea Pharmaceuticals, Inc. financials on 6ix · Atea Pharmaceuticals, Inc. on 6ix